We’re developing new partnerships in clinical medicine, biomedical research, and computing and systems biology to capitalise on the application of new immune therapies and diagnostic tools for monitoring patient response.
The recent development of immune therapies has been one of the most exciting evolutions in health care. Its implementation requires new partnerships between a range of specialties within clinical medicine and biomedical research, combined with computing and systems biology.
We engage a multidisciplinary team to develop therapies that harness the power of the immune system, together with new immune diagnostics.
By bringing previously disparate activities together, we’ll combine the creation of new immune therapies with the development of sophisticated diagnostic tools to predict and monitor patient responses.